Anticoagulation

Anticoagulation module 1: Introduction to antithrombotic therapy

Released 27 October 2021   Programme: Anticoagulation 1 CPD/CME credit

Anticoagulation module 1: Introduction to antithrombotic therapy
  • Understand the role of Virchow’s triad
  • Discuss the coagulation cascade
  • Recognise key aspects of platelet function
  • Appreciate the consequences of loss of haemostasis
  • Appreciate the importance of antiplatelet drugs in treating arterial thrombosis
  • Explain the role of anticoagulants in treating venous thrombosis

Anticoagulation module 2: Antiplatelet therapy

Released 27 October 2021   Programme: Anticoagulation 1 CPD/CME credit

Anticoagulation module 2: Antiplatelet therapy Upon completing this module, participants should be better able to:
  • Understand the importance of platelets in pathology
  • Be able to discuss the physiology of the platelet
  • Recognise three major routes for suppressing platelet function
  • Be aware of the mode of action of metabolic inhibitors
  • Appreciate the value of ADP-receptor blockers
  • Explain the uses of GpIIb/IIIa receptor blockers
  • Be prepared for the consequences of mis-management of antiplatelet therapy: haemorrhage

Anticoagulation module 3: Anticoagulant therapy

Released 27 October 2021   Programme: Anticoagulation 1.5 CPD/CME credits

Anticoagulation module 3: Anticoagulant therapy
  • Understand key aspects of the coagulation pathway
  • Discuss the action of heparin, low molecular weight heparin, fondaparinux and vitamin K antagonists such as warfarin
  • Recognise the mode of action of direct oral anticoagulants
  • Appreciate the uses of anticoagulants in acute coronary syndromes and atrial fibrillation
  • Prepare for the consequences of mis-managed anticoagulation, including haemorrhage.

Anticoagulation module 4: Clinical aspects of anticoagulation

Released 27 October 2021   Programme: Anticoagulation 1 CPD/CME credit

Anticoagulation module 4: Clinical aspects of anticoagulation
  • How to initiate anticoagulation with vitamin K antagonists (VKA)
  • Practical issues around VKAs and monitoring
  • When and how to use direct oral anticoagulants (DOACs)
  • Influence of DOACs on laboratory coagulation tests
  • Anticoagulation management around invasive procedures

Anticoagulation module 5: The role of the pharmacist

Released 27 October 2021   Programme: Anticoagulation 0.5 CPD/CME credits

Anticoagulation module 5: The role of the pharmacist
  • Discuss the role of the hospital and community pharmacist in the provision of anticoagulant services
  • Understand the initiation of anticoagulants, and patient counselling
  • Provide pragmatic advice on use of warfarin and direct oral anticoagulants

Anticoagulation module 6: Peripheral arterial disease, cancer, thrombosis and anticoagulation requirements

Released 27 October 2021   Programme: Anticoagulation 0.5 CPD/CME credits

Anticoagulation module 6: Peripheral arterial disease, cancer, thrombosis and anticoagulation requirements
  • Identify peripheral arterial disease and its management
  • Understand the risk factors for venous thromboembolism (VTE) and the management options with direct oral anticoagulants
  • Know about the prevalence of undiagnosed cancer in patients with an unprovoked VTE and the management of cancer-associated thrombosis